Marks Group Wealth Management »

Kymera Therapeutics shares owned by Marks Group Wealth Management

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Marks Group Wealth Management from 13F filings

Historical chart of Marks Group Wealth Management investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Marks Group Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Marks Group Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $507k 4.4k 114.67
2026-03-31 $333k 4.0k 83.29

More positions owned by Marks Group Wealth Management

Spdr Series Trust St Str P500etf (SPYM)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Eafe Grwth Etf (EFG)
Apple (AAPL)
Putnam Etf Trust Focused Lar Cap (PVAL)
Blackrock Etf Trust Isha I In Te Etf (BAI)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Eafe Value Etf (EFV)
Ishares Core Msci Emkt (IEMG)
Fidelity Covington Trust Momentum Factr (FDMO)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Invesco Exch Traded Fd Tr Ii S&p Intl Qulty (IDHQ)
Blackrock Etf Trust Isha La Core Etf (BLCR)
NVIDIA Corporation (NVDA)

View all positions for Marks Group Wealth Management

Top funds holding Kymera Therapeutics

FMR
Baker Bros. Advisors
venBio Select Advisor
T. Rowe Price Associates
BVF
BlackRock
Atlas Venture Life Science Advisors
Wellington Management Company
Siren
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Capital Research Global Investors
Geode Capital Management
Driehaus Capital Management

View all funds holding Kymera Therapeutics